Anzeige
Mehr »
Dienstag, 25.11.2025 - Börsentäglich über 12.000 News
Goldrausch 2.0: 60% Insideranteil - warum dieser Gold-Explorer als Geheimtipp gilt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von GlobeNewswire (Europe)

ZeitAktuelle NachrichtenRatingLeser
13:40Lifco AB: Lifco acquires DB Orthodontics in the UK33Lifco has signed an agreement to acquire all shares in the UK company DB Orthodontics Ltd. DB Orthodontics produces and sells orthodontics material to dental professionals in the UK and globally. In...
► Artikel lesen
13:36Electra Battery Materials Corporation Signs Agreement with North American pCAM Company105TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) ("Electra" or the "Company"), a leader in advancing North America's critical minerals processing...
► Artikel lesen
13:36B.O.S. Better Online Solutions Ltd.: BOS Continues Record Year Performance in Q3 2025, Sales Increase 16% Year-Over-Year201RISHON LE ZION, Israel, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. (BOSC) today reported financial results for the third quarter and nine months ended September 30, 2025, demonstrating...
► Artikel lesen
13:36Anavex Life Sciences Corp.: Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update338Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical...
► Artikel lesen
13:36Highland Copper Company Inc.: Highland Copper Signs Binding Offer from Kinterra to Sell 34% Interest in White Pine North for US$30 Million58VANCOUVER, British Columbia, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) ("Highland Copper" or the "Company") is pleased to announce that it has signed...
► Artikel lesen
13:36Creative Realities Announces Addition of Tamra Koshewa as CFO70LOUISVILLE, Ky, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions...
► Artikel lesen
13:36Jayud Global Logistics Ltd: Jayud Global Logistics Assumes Controlling Interest in Longgang Cross-Border E-Commerce Center230SHENZHEN, China, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing...
► Artikel lesen
13:36Abercrombie & Fitch Co. Reports Third Quarter Fiscal 2025 Results108Record third quarter net sales of $1.3 billion- up 7% from last year, 12th consecutive quarter of growthNet sales growth led by Americas up 7%, EMEA up 7%, partially offset by 6% decline in APACBrand...
► Artikel lesen
13:36Dragonfly Energy Holdings Corp.: Dragonfly Energy Broadens Product Lineup to Drive Growth Beyond Batteries103RENO, Nev., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and maker of Battle Born Batteries®...
► Artikel lesen
13:36Fusion Fuel Green PLC: Fusion Fuel's BrightHy Solutions Expands Green Hydrogen Footprint in Southern Europe with Agreement to Deliver New Electrolyzer and Hydrogen Refueling Station Project71Dublin, Ireland, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO) ("Fusion Fuel" or the "Company"), a leading provider of full-service energy engineering, advisory, and utility...
► Artikel lesen
13:10Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Exposition and provides a business progress update204AMX-883 shows synergistic efficacy in combination with venetoclax in vivo and prevents the emergence of resistance to venetoclax in vitro, addressing a major clinical challenge in acute myeloid leukaemia...
► Artikel lesen
13:10Colliers International Group Inc: Colliers named World's Best Real Estate Adviser for second straight year165Wins eight additional Euromoney awards across regional and country categoriesTORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Global diversified professional services and investment management company Colliers...
► Artikel lesen
13:10Denodo Technologies Inc. ("Denodo"): Denodo Named as a Leader in IDC MarketScape for Data Integration Software Platforms166PALO ALTO, Calif., Nov. 25, 2025, a leader in data management, announced that it has been recognized as a Leader in the IDC MarketScape: Worldwide Data Integration Software Platforms 2025 Vendor Assessment...
► Artikel lesen
13:06SPARC AI INC: SPARC AI Receives Delivery of Two Custom STRIKE-1 Drones194VANCOUVER, British Columbia, Nov. 25, 2025 (GLOBE NEWSWIRE) -- SPARC AI Inc. (the "Company") (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) SPARC AI has taken delivery of two custom-built STRIKE-1 drones....
► Artikel lesen
13:06Rubico Inc. Announces Time Charter Extensions and Contracted Revenue Backlog of $120.8 Million128ATHENS, Greece, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Rubico Inc. (NASDAQ: RUBI) (the "Company"), an international owner and operator of modern, fuel efficient "ECO" tanker vessels, announced today that...
► Artikel lesen
13:06Clearfield, Inc.: Clearfield Reports Fourth Quarter and Full Year 2025 Results138Fiscal 2025 Clearfield net sales from continuing operations grew 20% to $150.1 million; Gross margin improved by over 13 percentage points from 20.6% to 33.7% Fiscal 2025 Clearfield net income from...
► Artikel lesen
13:06OTC Markets Group Welcomes Compass Group PLC to OTCQX149NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Compass Group...
► Artikel lesen
13:06Kymera Therapeutics, Inc.: Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader104Data from the KT-621 BROADEN2 Phase 2b AD patient trial expected to be reported by mid-2027 KT-621 BREADTH Phase 2b trial in asthma on track to initiate in 1Q26 Completed dosing in KT-621 BroADen...
► Artikel lesen
13:00Lagercrantz Group AB: Lagercrantz acquires I Holland89Lagercrantz Group AB (publ) has today acquired 85% of the shares in I Holland Limited in the UK, a world-leading manufacturer of premium tablet compression tools for pharmaceutical tablet manufacturing. Specialising...
► Artikel lesen
12:48Titan Machinery Inc. Announces Results for Fiscal Third Quarter Ended October 31, 202591- Achieves $98 Million Cumulative Inventory Reduction in First Nine Months of Fiscal 2026 - - Increases Inventory Reduction Target for Fiscal 2026 to $150 Million (from $100+ Million Previously)...
► Artikel lesen
12:48Burlington Stores, Inc. Reports Third Quarter 2025 Earnings96Total sales grew 7% and comparable store sales increased 1% Net income was $105 million, and diluted EPS was $1.63 Excluding certain expenses associated with bankruptcy acquired leases: Adjusted...
► Artikel lesen
12:36Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance133PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month...
► Artikel lesen
12:34Nokia Oyj: Nokia announces delisting from Paris Stock Exchange487Nokia CorporationStock Exchange Release25 November 2025 at 13:30 EETNokia announces delisting from Paris Stock Exchange Espoo, Finland - Following its announcement on 4 November 2025 regarding...
► Artikel lesen
12:34Novo Nordisk A/S: Novo Nordisk phase 2 trial with amycretin reports significant weight loss and HbA1c reduction in type 2 diabetes407Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeksAmycretin demonstrated statistically significant reductions in HbA1c with up to 89.1% achieving HbA1c levels below 7%Amycretin...
► Artikel lesen
12:30Scanfil Oyj: Scanfil Establishes Two New Share-Based Incentive Plans for Key Employees6925.11.2025 13:30:00 EET | Scanfil Oyj | Other information disclosed according to the rules of the Exchange Scanfil plc Stock Exchange Release 25 November 2025 at 1.30 p.m. EET Scanfil Establishes...
► Artikel lesen